Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802/WJOG4607L.
lymph node metastasis
mediastinal lymph node dissection
non-small cell lung cancer
small
Journal
The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
02
08
2023
revised:
30
10
2023
accepted:
12
11
2023
medline:
25
11
2023
pubmed:
25
11
2023
entrez:
24
11
2023
Statut:
aheadofprint
Résumé
The optimal region of lymph node dissection (LND) during segmentectomy in patients with small peripheral non-small cell lung cancer requires clarification. Through a supplemental analysis of the JCOG0802/WJOG4607L, we investigated the associated factors, distribution, and recurrence pattern of lymph node metastases (LNM) and proposed the optimal LND region. Of the 1106 patients included in the JCOG0802/WJOG4607L, 1056 patients with LNDs were included in this supplemental analysis. We investigated the distribution and recurrence pattern of LNMs along with the radiological findings (with ground glass opacity [GGO], part-solid tumor; without GGO component, pure-solid tumor). The radiological findings were the only significant factor for LNMs. Of 533 patients with part-solid tumors, eight (1.5%) had LNMs. Further, only three (0.5%) patients had pN2 disease, and no patients had interlobar LNMs from non-adjacent segments. Of the 523 patients with pure-solid tumors, 55 (10.5%) had LNMs, and 28 (5.4%) had pN2 disease. Five patients had metastases to non-adjacent interlobar lymph nodes (LNs). Two (2.0%) patients with S6 tumors had upper mediastinal LNMs. In addition, the incidence of mediastinal LN recurrence in patients with S6 lung cancer was greater in those who underwent selective LND than those who underwent systematic LND (p = 0.0455). Non-adjacent interlobar and mediastinal LND have little impact on pathological nodal staging in patients with part-solid tumors. In contrast, selective LND is recommended at least for patients with pure-solid tumors.
Identifiants
pubmed: 38000629
pii: S0022-5223(23)01099-1
doi: 10.1016/j.jtcvs.2023.11.023
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023. Published by Elsevier Inc.